In another study wherein fluoxetin was administered to patients suffering from MDD, the baseline VEGF levels were significantly lower in healthy controls than in the MDD subgroup, and there were no significant changes in VEGF concentrations after 4 and 8 weeks of follow-up (11). This evidence concerns the gene VEGFA and major depressive disorder.